NCT04273282View on ClinicalTrials.gov

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Cataract
Interventions
DRUG

Dexycu intracameral dexamethasone

To evaluate the safety and ocular efficacy of Dexycu.

DRUG

Prednisolone Acetate

To evaluate the safety and ocular efficacy, and patient acceptance of post cataract surgery drug treatment regimen that minimizes topical medications.

Trial Locations (2)

11530

Ophthalmic Consultants of Long Island, Garden City

92653

Harvard Eye Associates, Laguna Hills

All Listed Sponsors
lead

Research Insight LLC

INDUSTRY

NCT04273282 - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% | Biotech Hunter | Biotech Hunter